期刊文献+

IL-27对哮喘患儿IFN-γ及IL-4的调节作用 被引量:14

Interleukin-27 affects IFN-γ and IL-4 activities in children with asthma
原文传递
导出
摘要 目的探讨白介素27(IL-27)对哮喘患儿干扰素γ(IFN-γ)及白介素4(IL-4)的调节作用。方法收集23例哮喘患儿外周血单个核细胞(PBMC),加入不同浓度(5ng/mL或0.5ng/mL)重组人白介素27(rhIL-27)进行体外培养12h,予酶联免疫吸附法(ELISA)测定其培养上清IFN-γ及IL-4浓度。结果 5ng/mL和0.5ng/mL两个浓度的rhIL-27刺激PBMC进行体外培养后,IFN-γ表达分别为85.9±12.2和8.9±2.3μg/L,较细胞刺激素组(7.2±1.3μg/L)均有显著升高(P<0.01或0.05)。5ng/mLrhIL-27组IL-4表达较细胞刺激素组有明显降低(15.0±1.9μg/Lvs77.0±15.6μg/L,P<0.01)。结论 IL-27参与了哮喘的发病过程,它可通过调节Th1/Th2相关细胞因子活性为哮喘治疗提供一种新的途径。 Objective To study the effect of interleukin(IL)-27 on INF and IL-4 activities in children with asthma.Methods The levels of IFN-γ and IL-4 in culture supernatants of peripheral blood mononuclear cells(PBMCs) from 23 asthmatic children were measured using ELISA.PBMCs were cultured with recombinant IL-27(5 ng /mL or 0.5 ng /mL)for 12 hrs in vitro.Results IFN-γ levels in both 5 ng /mL and 0.5 ng /mL IL-27 treatment groups(85.9 ± 12.2 and 8.9 ± 2.3 μg /L,respectively) increased compared with those in the cytokine stimulated control group(P〈0.01,P〈0.05 respectively).The group treated with 5 ng /mL IL-27 had decreased significantly IL-4 levels compared with the cytokine stimulated control group(15.0 ± 1.9 μg /L vs 77.0 ± 15.6 μg /L;P〈0.01).Conclusions IL-27 may be involved in the pathogenesis of asthma.It may affect Th1 /Th2 cell activities and might be a new option for the treatment of asthma.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2010年第7期521-523,共3页 Chinese Journal of Contemporary Pediatrics
基金 湖北省教育厅自然科学研究重点基金项目(No.2004X055)
关键词 哮喘 白介素27 T淋巴细胞 儿童 Asthma Interleukin-27 T lymphocyte Child
  • 相关文献

参考文献8

  • 1Lourenco O, Mafalda Fonseca A, Taborda-Barata L. T cells in sputum of asthmatic patients are activated independently of disease severity or control [ J ]. Allergol hnmunopathol, 2009, 37 (6) :285-292.
  • 2Nakanishi K, Tsutsui H, Yoshimoto T. Importance of IL/-18-induced super Th1 cells for the development of allergic inflammation [J]. Allergollnt, 2010, 59(2): 137-141.
  • 3陈杰,袁岳沙.白细胞介素-27与哮喘疾病的研究前景[J].中国医师进修杂志(内科版),2009,32(3):73-75. 被引量:5
  • 4中华医学会儿科学分会呼吸学组.儿童支气管哮喘诊断及防治指南.中华儿科杂志,2009,42(1):1-3.
  • 5Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EB I3 and p28 protein, induces proliferation of naive CD4^+ T cells[ J]. Immunity, 2002, 16 (6) :779-790.
  • 6Batten M, Li J, Kljavin NM, Danilenko DM, Lucas S, Lee J, et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. [J]. Nat Immunol, 2006, 7(9) :929-936.
  • 7Stumhofer JS, Laurence A, Wilson EH, Huang E, Tato CM, Johnson LM, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system [ J ]. Nat Immunol, 2006, 7(9) :937-945.
  • 8Yoshimoto T, Yoshimoto T, Yasuda K, Mizuguchi J, Nakanishi K. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells : a novel therapeutic way for Th2-mediated allergic inflammation[ J]. J Immunol, 2007, 179 (7) : 4415-4423.

二级参考文献19

  • 1Batten M, Li J, Yi S, et al. lnterleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol, 2006,7(9) : 929-936.
  • 2Stumhofer JS, Kaurence A, Wilson EH, et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat lmmunol, 2006,7(9) : 937-945.
  • 3Laruusserie F, Bardel E, Ptlanz S, et al. Analysis of interleukin-27 (EBI3/p28) expression in Epstein-Ban- virus- and human T-cell leukemia virus type 1-associated lymphomas: heterogeneous expression of EBI3 subunit by tumoral cells. Am J Pathol, 2005,166(4): 1217-1228.
  • 4Pflanz S, Hibbert L, Mattson J, et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol, 2004, 172(4): 2225-2231.
  • 5Scheller J, Schuster B, Holscher C, et al. No inhibition of IL-27 signaling by soluble gp130. Biochem Biophys Res Commun, 2005, 326(4) : 724-728.
  • 6Villarino AV, Larkin J 3rd, Saris CJ, ct al. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol, 2005, 174(12) : 7684-7691.
  • 7Yoshimoto T, Okada K, Morishima N, el al. Induction of IgG2a class switching in B cells by IL-27.J Immunol, 2004, 173 (4):2479-2485.
  • 8Owaki T, Asakawa M, Morishima N, et al. A role for IL-27 in early regulation of Th 1 differentiation. J Immunol, 2005,175 (4) : 2191 - 2200.
  • 9Artis D, Johnson LM, Joyce K, et al. Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Thl cytokine responses following Leishmania major infection. J Immunol, 2004, 172 (8): 4672- 4675.
  • 10Wirtz S, Tubbe I, Galle PR, et al. Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J Exp Med, 2006, 203(8): 1875-1881.

共引文献6

同被引文献156

引证文献14

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部